Treatment of motility disorders with a GNRH analog
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 18, 1995
Issued Date -
N/A
app pub date -
Oct 19, 1992
filing date -
Dec 14, 1990
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
A treatment to alleviate the debilitating symptoms of Motility Disorders, including Autonomic Neuropathies associated with autoimmune disease such as Systemic Lupus Erythematosis (SLE). Treatment of patients with analogs of GnRH significantly reduces or eliminates the symptoms of Motility Disorders, including that associated with SLE.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully